The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative...

por Drexler, Beatrice, Passweg, Jakob R., Tzankov, Alexandar, Bigler, Martin, Theocharides, Alexandre PA, Cantoni, Nathan, Keller, Peter, Stussi, Georg, Ruefer, Axel, Benz, Rudolf, Favre, Geneviève, Lundberg, Pontus, Nienhold, Ronny, Fuhrer, Andrea, Biaggi, Christine, Manz, Markus G., Bargetzi, Mario, Mendez-Ferrer, Simon, Skoda, Radek C.
Publicado 2019

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort

por Brune, Magdalena M., Stüssi, Georg, Lundberg, Pontus, Vela, Visar, Heim, Dominik, Manz, Markus G., Haralambieva, Eugenia, Pabst, Thomas, Banz, Yara, Bargetzi, Mario, Grobholz, Rainer, Fehr, Martin, Cogliatti, Sergio, Ossenkoppele, Gert J., Löwenberg, Bob, Rudolf, Christina Biaggi, Li, Qiyu, Passweg, Jakob, Mazzuchelli, Luca, Medinger, Michael, Tzankov, Alexandar
Publicado 2021